Fortrea Holdings's book value per share for the quarter that ended in Mar. 2024 was $17.93.
During the past 12 months, Fortrea Holdings's average Book Value Per Share Growth Rate was -11.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
Fortrea Holdings's current price is $25.55. Its book value per share for the quarter that ended in Mar. 2024 was $17.93. Hence, today's PB Ratio of Fortrea Holdings is 1.43.
During the past 4 years, the highest P/B Ratio of Fortrea Holdings was 2.18. The lowest was 1.32. And the median was 1.63.
Good Sign:
Fortrea Holdings Inc stock PB Ratio (=1.43) is close to 1-year low of 1.32
Fortrea Holdings Book Value per Share Historical Data
The historical data trend for Fortrea Holdings's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fortrea Holdings's Book Value per Share
For the Biotechnology subindustry, Fortrea Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortrea Holdings's PB Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Fortrea Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Fortrea Holdings's PB Ratio falls into.
Fortrea Holdings Book Value per Share Calculation
Fortrea Holdings's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Fortrea Holdings (NAS:FTRE) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Fortrea Holdings Book Value per Share Related Terms
Thank you for viewing the detailed overview of Fortrea Holdings's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Fortrea Holdings (Fortrea Holdings) Business Description
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FTRE has been successfully added to your 